Effects of Huayu Ruangan Capsules on CCl4-induced hepatic fibrosis in rats
XU Wen-juan,LI Hong-fang,NIU Yuan-yuan,MAO Lan-fang,DU Xiao-juan,LI Zheng-ju,ZHANG Ping,TAO Yong-biao,WANG Long-de
DOI: https://doi.org/10.3969/j.issn.1001-1528.2023.05.010
2023-01-01
Abstract:AIM To investigate the effects of Huayu Ruangan Capsules on hepatic fibrosis and its influence on Wnt/β-catenin signaling pathway in liver tissue of rats.METHODS In contrast to the 10 rats randomly assigned into the normal group, the other 50 rats were induced into hepatic fibrosis models with 6 weeks administration of CCl 4 , and further divided into the model group for colchicine group（0.2 mg/kg） and the low, medium and high dose groups of Huayu Ruangan Capsules（0.27, 0.54 and 1.08 g/kg）, 6 weeks intragastrical dosing of corresponding drug or saline water（twice daily）. The rats had their liver pathological changes observed by HE and Masson staining; their serum liver function（ALT, AST, TG, TBIL） and liver fibrosis indexes levels（HA, LN, PC-Ⅲ, Ⅳ-C） assessed by biochemical method and chemiluminescence method; their mRNA and protein expressions of Wnt1, Wnt3a, Wnt10, GSK-3β, β-catenin and c-Myc detected by RT-qPCR and Western blot; and their hepatic expressions of β-catenin and α-SMA protein detected by immunofluorescence.RESULTS Compared with the normal group, the model group was observed with pathological hepatic damage; increased levels of serum ALT, AST, TG, TBIL, HA, LN, PC-Ⅲ and Ⅳ-C（P＜0.01）; enhanced mRNA and protein expressions of Wnt1, Wnt3a, Wnt10, β-catenin and c-Myc（P＜0.01）; and decreased mRNA and protein expression of GSK-3β（P＜0.01）, in addition to the up-regulated hepatic protein expressions of α-SMA and β-catenin revealed by the result of immunofluorescence（P＜0.01）. Compared with the model group, the Huayu Ruangan Capsules groups shared differently improved pathological hepatic changes, weakened fluorescence intensity of α-SMA, restored serum liver function and liver fibrosis indicators levels（P＜0.05, P＜0.01）, reduced mRNA and protein expressions of Wnt1, Wnt3a, Wnt10, β-catenin, and c-Myc（P＜0.05, P＜0.01）, and increased mRNA and protein expression of GSK-3β（P＜0.05, P＜0.01）.CONCLUSION Huayu Ruangan Capsules can reduce the degree of liver fibrosis in rats, and its mechanism may associate with the regulations on the expressions of related genes and proteins in Wnt/β-catenin signaling pathway.